Metallothionein expression prevents apoptosis: A study with antisense phosphorothioate oligodeoxynucleotides in a human T cell line

Anticancer Research

Volumn 18, Issue 4 A, 1998, Pages 2423-2433

  Tsangaris, George Th ^a   Tzortzatou Stathopoulou, Fottni ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Antisense phoshorothioate oligonucleotides; Apoptosis; Inhibition; Metallothionein; T cell line

Indexed keywords

CELL PROTEIN; DNA FRAGMENT; METALLOTHIONEIN; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; THIOL;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; ENVIRONMENTAL FACTOR; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

APOPTOSIS; BASE SEQUENCE; CELL SURVIVAL; CULTURE MEDIA; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KINETICS; LEUKEMIA, T-CELL; METALLOTHIONEIN; OLIGONUCLEOTIDES, ANTISENSE; THIONUCLEOTIDES; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0031811526     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kaji JHR and Kojima Y: Metallothionein II, Birkhauser Verlag, Basel, (1987).
2. Suzuki KT, Imura N and Kimura M: Metallothionein III, Birkhauser Verlag, Basel, (1993).
3. Skroch P, Buchman C and Karin M: Regulation of human and yeast metallothionein gene transcription by heavy metal ions. Prog Clin Biol Res 380: 113-128, 1993.
4. Hamer DH: Metallothionein. Annu Rev Biochem 55; 913-915, 1987.
5. Hildalgo J, Giralt M, Garvey JS and Armario A: Physiological role of glucocorticoids on rat serum and liver metallothionein in basal and stress conditions. Am J Physiol 254: 71-82, 1988.
6. Sadhu C and Gedamu L: Regulation of human metallothionein (MT) genes. Differential expression of MTI-F, MTI-G and MTII-A genes in the hepatoblastoma cell line (HepG2). J Biol Chem 263: 2679-2684, 1988.
7. Kondo Y, Kuo SM and Lazo JS: Interleukin-1 ß-mediated metallothionein induction and cytoprotection against cadmium and cic-diamminedichloroplatinum. J Pharmacol Exp Ther 270: 1313-1318, 1994.
8. Cosma GN, Currie D, Squibb KS, Snyder CA and Garte SJ: Detection of cadmium exposure in rats by induction of lymphocyte metallothionein gene expression. J Toxicol Env Health 34: 39-49, 1991.
9. Cherian MG, Huang PC, Klaasen CD, Liu YP, Longfellow DG and Waakes MP: National cancer institute workshop on the possible roles of metallothionein in carcinogenesis. Cancer Res 53: 922-925, (1993).
10. Basu A and Lazo JS: A hypothesis regarding the protective role of metallothioneins against the toxicity of DNA interactive anticancer drugs. Toxicol Lett 50: 123-135, 1990.
11. Kelly SL, Basu A, Teicher BA, Hacker MP, Hamer DH and Lazo JS: Overexpression of metallothionein confers resistance to anticancer drugs Science 241: 1813-1815, 1988.
12. Iversen PL and Ebadi M: Antisence oligonucleotide-mediated inhibition of metallothionein protein synthesis in neuroblastoma IMR 32 and Chang Liver cells in culture. Biol Signals 1: 57-64, 1992.
13. Iversen PL, Mata JE and Ebadi M: Synthetic antisense oligonucleotide prodes the essentiality of metallothionein gene. Biol Signals 1: 293-299, 1992.
14. Karin M and Richards R: Human metallothionein genes-primary structure of metallothionein II gene and a related processed gene. Nature 299: 797-802, 1982.
15. Tsangaris GTh and Tzortzatou-Stathopoulou F: Development of a quantitative method for the study of apoptosis in peripheral blood. In Vivo 10: 435-444, 1996.
16. Satoh MM, Cherian G, Imura N and Shimizu H: Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis. Cancer Res 54: 5255-5257, 1994.
17. El Azzouzi B, Tsangaris GTh, Pellegrini O, Manuel Y, Benveniste J and Thomas Y: Cadmium induces apoptosis in a human T cell line. Toxicology 88: 127-139, 1994.
18. Masters BA, Kelly EJ, Quaife CJ, Brister RL and Palmiter RD: Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc Natl Acad Sci USA 91: 584-588, 1994.
19. Iversen P: In vivo studies with phosphorothioate oligonucleotides: pharmacokinetics prologue. Anti-Cancer Drug Des 6: 531-538, (1991).
20. Hannun YA: Apoptosis and the dilemma of cancer chemotherapy. Blood 89: 1845-1853, 1997.
21. Pellegrini O, Davenas E, El Azzouzi B, Jurgens P, Benveniste J, Manuel Y and Thomas Y: Stress proteins in human lymphocytes. I: Induction of metallothionein and heat shock protein genes by cadmium in an immature T cell line. Cell Pharmacol 1: 91-97, 1994.
22. 2+ in a human T cell line. Eur J Pharmacol 270: 221-228, 1994.
23. Skorch P, Buchman C and Karin M: Regulation of human and yeast metallothionein gene trancription by heavy metal ions. Prog Clin Biol Res 380: 113-128, 1993.
24. Thonally PJ and Vasak M: Possible for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with Superoxide and hydroxyl radicals. Biochim Biophys Acta 827: 36-66, 1985.
25. Murphy BJ, Laderoute KR, Clin RJ and Sutherland RM: Metallothionein IIA is up-regulated by hypoxia in human A431 squamous carcinoma cells. Cancer Res 54: 5808-5810, 1994.
26. McConkey DJ, Hartzell P, Nicotera P, Wyllie AH, Orrenius S: Stimulation of endogenous endonuclease in cells exposed to oxidative stress. Toxicol Lett 42: 123-130, 1988.
27. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL and Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75: 241-251, 1993.
28. Tsangaris GTh and Tzortzatou-Stathopoulou F: The role of the differential cadmium-induced apoptosis on the immune system cells. Br J Haemat 93: S2, 294-295, 1996.
29. Sauerbrey A, Zintl F and Volm M: Expression of metallothionein in initial and relapsed childhood acute lymphoblastic leukemia. Ann Hematol 69: 111-115, (1994).
30. Kotoh S, Naito S, Sakamoto N, Goto K and Kumazawa J: Metallothionein expression is correlated with cisplatin resistance in transitional cell carcinoma of the urinary tract. J Urology 52: 1267-1270, 1994.
31. Sundelin K, Jadner M, Norberg-Spaak L, Davinson A and Hellquist HB: Metallothionein and Fas (CD95) are expressed in squamous cell carcinoma of the tongue. Eur J Cancer 33: 1860-1864, 1997.